François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth
MONTREAL--(BUSINESS WIRE)-- Innospera Pharma Inc. ('Innospera'), a private, near-clinical-stage biotechnology company focused on developing small-molecule modulators of GPR84 and GPR40 to address a broad range of inflammatory and metabolic diseases with high unmet medical needs, today announced the appointment of François Ravenelle, PhD, as President and Chief Executive Officer, effective immediately.
"With strong preclinical evidence and the potential to address chronic conditions such as idiopathic pulmonary fibrosis, Innospera is uniquely positioned to make a meaningful impact in the field of inflammatory-related conditions." - François Ravenelle
Share
Dr. Ravenelle is an accomplished biotech leader with over two decades of experience in pharmaceutical R&D and executive management. He most recently served as President and CEO of Inversago Pharma, a clinical-stage company developing therapies based on peripheral CB1 receptor blockade to treat metabolic and fibrotic diseases. Under his leadership, Inversago raised more than $100M, and was acquired by Novo Nordisk for up to approximately $1 billion USD.
'I'm thrilled to join Innospera at this pivotal stage, as the company moves toward clinical development with a lead asset that shows strong potential for an exceptional balance of safety and efficacy in targeting inflammatory and metabolic pathways,' said Dr. Ravenelle. 'With strong preclinical evidence and the potential to address chronic conditions such as idiopathic pulmonary fibrosis, Innospera is uniquely positioned to make a meaningful impact in the field of inflammatory-related conditions. I'm excited to contribute to the company's next phase of growth.'
Pierre Laurin, Executive Chairman of the Board, founder and former CEO, commented: 'François' appointment comes at the perfect time following the completion of our seed financing round. His proven leadership and strategic vision will be invaluable as we prepare for clinical development and beyond. Investissement Québec, Seido Capital, and Anges Québec worked synergistically together to support Innospera's vision, based on the strong potential of our lead assets. We are privileged to work in one of the best life science clusters in North America, where innovation is recognized by quality investors, acting together as catalysts for promising endeavours like ours.'
About Long-term Inflammation
Systemic inflammation (inflammaging), increases as a consequence of aging contributing to age-related morbidities. Persistent activation of fibrotic pathways and organ dysfunction is markedly more frequent in the elderly (fibroaging). Elderly individuals with chronic disorders tend to develop inflammaging, a condition associated with elevated levels of blood inflammatory markers and increased susceptibility to chronic disease progression. Chronic, low-grade inflammation is a crucial contributor to various age-related pathologies and natural processes in aging tissue, including the lung, kidney, heart, liver, nervous and the musculoskeletal system.
About Innospera
Innospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions. The company's lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with dire short-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs. For more information, visit innospera.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
16 minutes ago
- Business Upturn
Nuvama downgrades Coal India stock to ‘Reduce'; cuts target price to Rs 367 on weak volumes, rising costs
Nuvama Institutional Equities has downgraded Coal India Ltd (CIL) to 'Reduce' from 'Hold', citing continued earnings pressure due to weak power demand, lower e-auction prices, and rising competition from captive coal miners. By Markets Desk Published on June 12, 2025, 07:55 IST Nuvama Institutional Equities has downgraded Coal India Ltd (CIL) to 'Reduce' from 'Hold' , citing continued earnings pressure due to weak power demand, lower e-auction prices, and rising competition from captive coal miners. The brokerage has revised its target price to ₹367 from ₹405 earlier, valuing the stock at 5x FY27E EV/EBITDA. Coal India has started FY26 on a soft note, with sales volume declining ~4.7% year-on-year during April–May 2025. Nuvama expects this trend to continue through June, as overall power demand fell 1.6% YoY during the pre-monsoon period, and captive coal players continue to gain share. Data from the Ministry of Coal shows that volume from captive and commercial mines rose 14.5% YoY to ~35 million tonnes in April–May 2025, capturing ~20% of demand, up from 17.5% in the same period last year. During FY25, captive players consumed 197 million tonnes, growing 31% YoY. With captive mine capacity peaking at 575 mtpa, Nuvama sees even Coal India's 2–3% volume CAGR target at risk. Nuvama has trimmed its volume estimates by 2% for both FY26 and FY27 to 770 mt and 793 mt, respectively — implying just 2% CAGR over FY25–27. High inventory, rising costs to impact margins Coal India's coal inventory at end-May 2025 stood at ~112 million tonnes, significantly above the five-year average of 83 million tonnes, restricting any meaningful production increase. Management has guided for a rise in the stripping ratio to 2.67x in FY26 (vs 2.58x in FY25), which will push cost of production (CoP) higher due to increased overburden removal without corresponding volume growth. Nuvama expects CoP to grow at 4% CAGR to ₹1,422 per tonne by FY27, factoring in wage revision-related cost increases in FY27. Limited operating leverage from stagnant production will further weigh on earnings. Lower e-auction realisations add to pressure Adding to the challenges is the continued decline in e-auction realisations. Benchmark Indonesia thermal coal (6323 kcal) prices have dropped to USD 115/t, down from earlier highs, and Nuvama believes further downside is possible. Coal India's e-auction prices have dropped from ₹2,615/t in Q4FY25 to ₹2,200–2,300/t currently. The brokerage now factors in an average realisation of ₹2,200/t in FY26 and ₹2,100/t in FY27. Despite these headwinds, Coal India's high dividend yield (~6%) remains its only bright spot. However, Nuvama noted that it prefers growth-focused opportunities, which are currently lacking for Coal India. The brokerage expects EBITDA to fall at a 2% CAGR over FY25–27, reinforcing its cautious stance. Disclaimer: The views and target prices mentioned are as stated by Nuvama and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
Business Wire
an hour ago
- Business Wire
Provenir to Moderate Panel Discussion on Digital Identity and Authentication for Malaysian Fraud Prevention at the AI, Cloud & Cybersecurity Congress 2025
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)-- Provenir: WHAT: Malaysia has suffered a staggering RM54.02 billion in losses due to financial scams, underscoring the urgent need for stronger fraud prevention measures. The financial crime landscape in Malaysia is becoming increasingly complex, and organizations need the most advanced technology in place to thwart these threats. Highlighting the importance of this issue, Kavinesswaran Karthigasan, APAC Regional Sales Director and Principal Consultant with Provenir, will moderate a panel discussion on 'The Digital Identity & Authentication – Building Trust in Malaysia's Digital Banking Ecosystem,' as part of The AI, Cloud & Cybersecurity Congress 2025 event in Kuala Lumpur, Malaysia next week. Panelists include representatives from CIMB, Maybank, Boost Bank and Standard Charter. The session will highlight how Malaysian banks can enhance digital identity verification, implement AI-driven authentication systems, and the role of Open Finance frameworks. Karthigasan will also host a panel on 'Scaling Bank-Fintech Partnerships in Malaysia – From Collaboration to Success,' with panelists from SC Ventures, GX Bank and BCS. WHEN: The panel discussions will take place June 17 at the Mandarin Oriental Kuala Lumpur, Malaysia, as part of The AI, Cloud & Cybersecurity Congress 2025, designed to deliver practical strategies and insights that financial leaders can implement immediately. The event is organized by The Digital Banker and gathers thought leaders, regulators, and innovators to explore how cloud technologies, artificial intelligence, and cybersecurity can drive resilience, efficiency, and innovation in banking in Malaysia. About Provenir Provenir helps banks, fintechs and financial services providers unlock the secret to smarter risk decisioning. Provenir's AI Decisioning Platform brings together the power of decisioning, data, and decision intelligence to drive smarter decisions. This unique offering gives organizations the ability to power decisioning innovation across the full customer lifecycle, driving improvements in the customer experience, best-in-class fraud prevention, access to financial services, business agility, and more. Provenir works with disruptive financial services organizations in more than 60 countries and processes more than 4 billion transactions annually.
Yahoo
2 hours ago
- Yahoo
VeriSilicon's AI-ISP Custom Chip Solution Enables Mass Production of Customer's Smartphones
Providing architecture design, software-hardware co-development, and mass production support, and enhancing AI-powered imaging capabilities in smart devices SHANGHAI, June 12, 2025--(BUSINESS WIRE)--VeriSilicon ( recently announced that its AI-ISP custom chip solution has been successfully adopted in a customer's mass-produced smartphones, reaffirming the company's comprehensive one-stop custom silicon service capabilities in AI vision processing. VeriSilicon's AI-ISP custom chip solution can integrate proprietary or third-party Neural Network Processing Unit (NPU) IP and Image Signal Processing (ISP) IP. By combining traditional image processing techniques with AI algorithms, it significantly enhances image and video clarity, dynamic range, and environmental adaptability. The chip solution offers flexible configurations with RISC-V or Arm-based processors, supports MIPI image input/output interfaces, provides LPDDR5/4X memory integration capability, and is compatible with common peripheral interfaces such as UART, I2C, and SDIO. This makes the solution highly adaptable for deployment across various applications including smartphones, surveillance systems, and automotive electronics. For this collaboration, VeriSilicon designed a low-power AI-ISP system-on-chip (SoC) based on the RISC-V architecture, tailored to the customer's specific requirements. It also included a FreeRTOS real-time Software Development Kit (SDK). The customized SoC was fully optimized for seamless interoperability with the customer's main processor platform and has since been successfully deployed in multiple smart devices, achieving large-scale production. This success highlights VeriSilicon's robust capabilities in heterogeneous computing, software-hardware co-optimization, and system-level integration and verification. "AI-powered imaging has become a key differentiator in the competitive smartphone market, driving increasing demand for high-performance and low-power image processing solutions," said Wiseway Wang, Executive Vice President and General Manager of the Custom Silicon Platform Division at VeriSilicon. "With full-spectrum capabilities ranging from IP licensing and chip architecture design to system-level software and hardware development, tape-out, packaging and testing, as well as mass production, VeriSilicon offers end-to-end custom silicon services leveraging its extensive design service experience and proven mass production capabilities. The successful mass production of this customer's chip further validates our strength in high-end silicon design services. Moving forward, we will continue to innovate and improve our offerings, empowering customers to accelerate the launch of differentiated products with efficient, high-quality custom chip solutions." About VeriSilicon VeriSilicon is committed to providing customers with platform-based, all-around, one-stop custom silicon services and semiconductor IP licensing services leveraging its in-house semiconductor IP. For more information, please visit: View source version on Contacts Media Contact: press@ Sign in to access your portfolio
